Dermatology Webkit

This page will bring together all of the PrescQIPP dermatology resources. Each set of resources includes tools that can be adapted for local use before implementation.

Dermatology - General Resources

Dermatology Snapshot

Data_snapshot.pngDermatology Snapshot

element locked This element is only available to subscribers - if you're a subscriber then please  LOGIN or register to view.

Dermatology Webinar

In this webinar Lindsay Wilson discusses PrescQIPP resources relating to both emollient and topical corticosteroid prescribing. Sajida Khatri looks at two further PrescQIPP dermatology bulletins on the subjects of Dovobet® in psoriasis, and shampoos and other scalp preparations.

element locked This element is only available to subscribers - if you're a subscriber then please  LOGIN or register to view.

Eczema and Psoriasis

The resources below discuss the use of steroid treatments in eczema and psoriasis, including psoriasis of the scalp.

B116: Topical Corticosteroids

This bulletin discusses the topical steroids used to treat skin conditions such as such as eczema and psoriasis, the bulletin and associated support material focus on ensuring good practice, prescribing appropriate quantities, regular review of topical steroid treatment and rational product selection.

   Bulletin 116. Topical corticosteroids

   Bulletin 116. Topical corticosteroids - Briefing

   Attachment 1. Topical corticosteroids audit

B90: Calcipotriol/Betamethasone (Dovobet) in Psoriasis

This bulletin focuses on the appropriate use of Dovobet® in treating psoriasis and discusses the concerns about long term continuous use. It provides guidance and support for those wishing to review prescribing and ensure it is only used intermittently with safer alternatives. As well as the usual briefing, audit and patient materials, a suggested pathway and aide memoire are also available.  

   Bulletin 90 Dovobet for psoriasis

   Bulletin 90 Dovobet for psoriasis - Briefing

   Bulletin 90 Dovobet for psoriasis - aide memoire

   Bulletin 90 Dovobet for psoriasis - Algorithm

   Attachment 1 Dovobet patient invite letter

   Attachment 2 Dovobet audit

B118: Shampoos and Other Scalp Preparations

This bulletin focuses on shampoos and scalp preparations for the treatment of psoriasis of the scalp and seborrhoeic dermatitis. It discusses appropriate use of these products, including duration of treatment.  

   Bulletin 118 Shampoos and scalp preparations

   Bulletin 118 Shampoos and scalp preparations - Briefing

   Attachment 1 - Algorithm for topical treatment of scalp psoriasis

   Attachment 2 - Audit - shampoos and scalp

   Attachment 3 - Patient invite letter - shampoos and scalp

Emollients

B76: Cost Effective Prescribing of Emollients

Emollients have a key role in treating dry skin conditions, including eczema and psoriasis. This bulletin is intended to guide cost effective and preferred emollient choice when initiating or changing emollient therapy. 

   Bulletin 76. Cost-effective and appropriate prescribing of emollients

   Bulletin 76. Cost-effective and appropriate prescribing of emollients - Briefing

   Attachment 1 Emollients PIL

B49: Cost Effective Emollients With No, or Low Paraffin Content

This bulletin discusses issues raised by the NPSA regarding a potential fire risk with the use of paraffin-based emollients. It highlights emollient products which have low or no paraffin content to support healthcare professionals who are optimising emollient treatment in line with the NPSA alert and for patients receiving oxygen therapy.

   Bulletin 49 - Cost effective emollients with no, or low paraffin content

DROP-List Items

The following items are on the DROP-List and should be reviewed as they are considered low priority treatments, have little evidence to support their use or can be considered as self care. 

B55: Topical Antifungal Nail Treatment Review

This bulletin focuses on topical antifungal nail treatments, i.e. amorolfine 5% nail lacquer (Loceryl®, Curanail®, Omicur®), tioconazole 28% cutaneous solution (Trosyl®) and salicylic acid, tannic acid and boric acid paint (Phytex®) which are low priority treatments. It includes information about the efficacy of both systemic and topical treatments, and discusses when self-care with topical treatments may be considered. 

   Bulletin 55 Amorolfine 5% nail lacquer

   Bulletin 55 Amorolfine 5% nail lacquer - Briefing

   Bulletin 55 Attachment 1 - Amorolfine - Patient letter review

   Bulletin 55 Attachment 2 - Amorolfine audit

B57: Eflornithine Review

This bulletin focuses on eflornithine 11.5% cream, which is a low priority treatment. It recommends that self-funded cosmetic treatments should be the primary option for facial hirsutism for the majority of women.

   Bulletin 57 Eflornithine

   Bulletin 57 Eflornithine - Briefing

   Eflornithine - Audit

  Eflornithine - Patient letter

   Eflornithine - Patient letter review

B60: Minocycline Use in Acne Vulgaris

This bulletin discusses safety concerns relating to the use of minocycline and provides the rationale for new patients to be commenced on an alternative antibiotic and for current patients to be considered for a switch to an alternative antibiotic.

   Bulletin 60 Minocycline

   Bulletin 60 Minocycline - Briefing

   Minocycline Attachment 1 - Audit

 Minocycline Attachment 2 - Patient letter